Etxeberria A, Shen YA, Vito S, Silverman S, et al. Neutral or detrimental effects of TREM2 agonist antibodies in preclinical models of Alzheimer's Disease and Multiple Sclerosis. J Neurosci 2024 Jun 3:e2347232024. doi: 10.1523/JNEUROSCI.2347-23.2024.
PMID: 38830764